Literature DB >> 3004249

Humoral autoimmune manifestation in subacute thyroiditis.

H Bliddal, K Bech, U Feldt-Rasmussen, M Høier-Madsen, B Thomsen, H Nielsen.   

Abstract

To study the autoimmune manifestations in subacute thyroiditis (SAT), the patterns of thyroid antibodies, thyroglobulin and circulating immune complexes were investigated in 10 patients during the course of the disease. Eight patients were thyrotoxic at diagnosis, and became euthyroid during recovery with a median observation of 8 months (4-30 months). Thyroid stimulating immunoglobulins were measured as TSH binding inhibiting immunoglobulins (TBII) and as thyroid stimulating antibodies (TSAb). TBII were present in all patients at least once during the observation period and remained detectable in six patients after recovery. TSAb were detected in three patients without relation to the hyperthyroid state. Thyroglobulin antibodies (TgAb) were present in four patients and persisted in three, while microsomal antibodies (MAb) were negative. Thyroglobulin (Tg) in the TgAb negative patients (n = 6) was high at diagnosis (median 229 micrograms/l, range 55-375) and fell rapidly during the course of SAT. Circulating immune complexes (CIC), which were found in all patients, reached maximal levels shortly after the onset of the disease and persisted after recovery. No correlation could be demonstrated between the different thyroid antibodies, and there was no clear relation between the levels of CIC and presence of the autoantibodies. However, the changes in CIC paralleled the changes in TBII, and it is suggested that immune complex formation is a major feature of the regulatory mechanisms controlling the immune responses in SAT.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3004249     DOI: 10.1111/j.1398-9995.1985.tb00889.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  2 in total

1.  Pathogenetic role of thyrotropin receptor antibody in the development of hyperthyroidism following primary hypothyroidism.

Authors:  Y K Shong; B Y Cho; S K Hong; H K Lee; C S Koh; H K Min
Journal:  Korean J Intern Med       Date:  1989-07       Impact factor: 2.884

2.  Elevated Graves' Disease-Specific Thyroid-Stimulating Immunoglobulin and Thyroid Stimulating Hormone Receptor Antibody in a Patient With Subacute Thyroiditis.

Authors:  Anu Alvin Mathew; Roshin Papaly; Alvin Maliakal; Lakshya Chandra; Mc Anto Antony
Journal:  Cureus       Date:  2021-11-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.